R1.3d Identify at least one (1) program-based Retention In Care Quality Improvement Opportunity Part A/MAI 1 per year (identify, pilot-test, evaluate, implement QM improvement). R1.4 R1.4a Provide Monitor quality and appropriateness of OMC continuous clinical care through client satisfaction surveys, focus improvements groups, targeted in reviews of SDIS data and clinical outpatient record reviews medical and improve through various technical Part A/MAI care assistance that meets methods the (on site QM TA, AETC, etc.). QM needs Require and corrective identified actions for providers with identified vulnerabilities deficiencies. of This is an ongoing set of processes. Note PLWHA that data in care. from the Client Satisfaction Survey will be available in the October meeting. R1.4b Monitor quality and appropriateness of prescription of non-ARV medication, to identify unusual prescription drug patterns reflecting problems in quality of care, through statistical analysis of prescribing frequency and/or desk audits of prescription patterns Part A/MAI for particular providers and improve prescribing QM patterns of these non-ARV medications as needed for appropriateness and cost effectiveness. Require corrective actions for providers with identified deficiencies. This is an ongoing set of processes. Reports will be provided in October.
R1.3d Identify at least one (1) program-based Retention In Care Quality Improvement Opportunity per year (identify, pilot-test, evaluate, implement improvement). Part A/MAI QM 1 R1.4 Provide continuous improvements in outpatient medical care that meets the needs and identified vulnerabilities of PLWHA in care. R1.4a Monitor quality and appropriateness of OMC clinical care through client satisfaction surveys, focus groups, targeted reviews of SDIS data and clinical record reviews and improve through various technical assistance methods (on site QM TA, AETC, etc.). Require corrective actions for providers with identified deficiencies. This is an ongoing set of processes. Note that data from the Client Satisfaction Survey will be available in the October meeting. Part A/MAI QM R1.4b Monitor quality and appropriateness of prescription of non-ARV medication, to identify unusual prescription drug patterns reflecting problems in quality of care, through statistical analysis of prescribing frequency and/or desk audits of prescription patterns for particular providers and improve prescribing patterns of these non-ARV medications as needed for appropriateness and cost effectiveness. Require corrective actions for providers with identified deficiencies. This is an ongoing set of processes. Reports will be provided in October. Part A/MAI QM
Miami_EMA_IP_PROGRESS_-_CY_2017_4-10-17.docx